Eton Pharma Q4 product sales $21.3M (+83% YoY); guides FY26 rev >$110M, 30%+ EBITDA margin

Eton Pharmaceuticals, Inc.

Q4 product sales $21.3M (+83% YoY); GAAP diluted EPS $0.05, non-GAAP diluted EPS $0.19; Adj. EBITDA $6.2M
Launched DESMODA (first FDA-approved desmopressin oral solution) on March 9, 2026
Acquired U.S. rights to Orphan Drug HEMANGEOL; relaunch May 1, 2026; accretive to 2026 earnings
FY 2026 guidance: revenue >$110M, Adj. EBITDA margin >30%
Cash $25.9M at Dec 31, 2025; net income $1.5M vs loss $5.4M prior year

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.91

Eton Pharmaceuticals, Inc. reported the fourth quarter and twelve months ended December 31, 2025 results: revenue $21.3 million, EPS basic GAAP EPS of $0.06, fully diluted GAAP EPS of $0.05, basic non-GAAP EPS of $0.21, fully diluted non-GAAP EPS of $0.. Guidance raised.

Period: the fourth quarter and twelve months ended December 31, 2025
Revenue: $21.3 million
EPS: basic GAAP EPS of $0.06, fully diluted GAAP EPS of $0.05, basic non-GAAP EPS of $0.21, fully diluted non-GAAP EPS of $0.
Guidance: raised
Result: reported results

Exact text from the filing

--- EX-99.1 2 ex_889836.htm EXHIBIT 99.1 ex_889836.htm Exhibit 99.1 Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results ● Q4 2025 product sales of $21.3 million, representing 83% growth over Q4 2024 ● Q4 2025 basic GAAP EPS of $0.06, fully diluted GAAP EPS of $0.05, basic non-GAAP EPS of $0.21, fully diluted non-GAAP EPS of $0.19, and

View on SEC.gov

Browse all earnings releases →

Eton Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-009060

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.